BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 8, Issue 35
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (9008)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.
Item 
Count 
PDF550
WORD189
HTML3979
Figures (1-1)510
Tables (1-1)524
 Sum=5752
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1379
Download1876
 Sum=3255
Dec 18, 2016 (publication date) through Oct 26, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews
Copyright ©The Author(s) 2016.
World J Hepatol. Dec 18, 2016; 8(35): 1541-1546
Published online Dec 18, 2016. doi: 10.4254/wjh.v8.i35.1541
Table 1 Parameters of post-progression survival for patients receiving sorafenib
Performance status
Child-Pugh class
BCLC class
CLIP score
Macroscopic venous invasion
AFP serum level
TTP on sorafenib
Pattern of progression
BCLC: Barcelona Clinic Liver Cancer staging classification; CLIP: Cancer of the Liver Italian Program; AFP: Alpha-fetoprotein; TTP: Time to progression.
Full Size Table
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345